Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
24 hedge funds and large institutions have $23M invested in Chembio diagnostics, Inc. in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 5 closing their positions.
16% more capital invested
Capital invested by funds: $19.8M → $23M (+$3.2M)
4% less funds holding
Funds holding: 25 → 24 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$976K |
| 2 |
AIP
ARS Investment Partners
New York
|
+$954K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$165K |
| 4 |
Goldman Sachs
New York
|
+$155K |
| 5 |
RA
Royce & Associates
New York
|
+$137K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$472K |
| 2 |
NJBEST
New Jersey Better Educational Savings Trust
Trenton,
New Jersey
|
-$425K |
| 3 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$294K |
| 4 |
CPIM
Columbia Partners Investment Management
Alexandria,
Virginia
|
-$259K |
| 5 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
-$209K |
CEMI Hedge Fund Activity: Q2 2017 in Review
24 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q2 2017, worth a combined $23M — up 16% from $19.8M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CEMI and 4 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 4 added.
The largest buyer was Acuta Capital Partners, adding an estimated $976K. The largest seller was Wellington Management Group, cutting an estimated $472K.
- 24 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q2 2017, down from 25 in Q1 2017.
- Funds reported $23M of Chembio diagnostics, Inc. stock for Q2 2017, up 16% quarter-over-quarter.
- 4 funds opened new Chembio diagnostics, Inc. positions in Q2 2017 and 5 closed out, a net change of -1 holder.
- The largest Chembio diagnostics, Inc. buyer in Q2 2017 was Acuta Capital Partners, an estimated $976K added.
- The largest Chembio diagnostics, Inc. seller in Q2 2017 was Wellington Management Group, an estimated $472K sold.
Based on aggregated 13F filings for Q2 2017.